EKTAY
Price
$4.41
Change
+$0.06 (+1.38%)
Updated
Nov 21 closing price
Capitalization
1.71B
Intraday BUY SELL Signals
SAUHY
Price
$12.07
Change
+$0.44 (+3.78%)
Updated
Nov 21 closing price
Capitalization
19.12B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EKTAY vs SAUHY

Header iconEKTAY vs SAUHY Comparison
Open Charts EKTAY vs SAUHYBanner chart's image
Elekta AB
Price$4.41
Change+$0.06 (+1.38%)
Volume$14.92K
Capitalization1.71B
Straumann Holding AG
Price$12.07
Change+$0.44 (+3.78%)
Volume$210.74K
Capitalization19.12B
EKTAY vs SAUHY Comparison Chart in %
EKTAY
Daily Signal:
Gain/Loss:
SAUHY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EKTAY vs. SAUHY commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKTAY is a Hold and SAUHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (EKTAY: $4.41 vs. SAUHY: $12.07)
Brand notoriety: EKTAY and SAUHY are both not notable
EKTAY represents the Medical/Nursing Services, while SAUHY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EKTAY: 262% vs. SAUHY: 105%
Market capitalization -- EKTAY: $1.7B vs. SAUHY: $19.12B
EKTAY [@Medical/Nursing Services] is valued at $1.7B. SAUHY’s [@Pharmaceuticals: Other] market capitalization is $19.12B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $222.77B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $199.09B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.62B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKTAY’s FA Score shows that 2 FA rating(s) are green whileSAUHY’s FA Score has 0 green FA rating(s).

  • EKTAY’s FA Score: 2 green, 3 red.
  • SAUHY’s FA Score: 0 green, 5 red.
According to our system of comparison, EKTAY is a better buy in the long-term than SAUHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKTAY’s TA Score shows that 4 TA indicator(s) are bullish while SAUHY’s TA Score has 5 bullish TA indicator(s).

  • EKTAY’s TA Score: 4 bullish, 6 bearish.
  • SAUHY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SAUHY is a better buy in the short-term than EKTAY.

Price Growth

EKTAY (@Medical/Nursing Services) experienced а -6.44% price change this week, while SAUHY (@Pharmaceuticals: Other) price change was -5.11% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.32%. For the same industry, the average monthly price growth was -6.15%, and the average quarterly price growth was +9.87%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.94%. For the same industry, the average monthly price growth was +2.64%, and the average quarterly price growth was +10.24%.

Reported Earning Dates

SAUHY is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.32% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.94% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAUHY($19.1B) has a higher market cap than EKTAY($1.71B). EKTAY has higher P/E ratio than SAUHY: EKTAY (58.44) vs SAUHY (36.14). SAUHY YTD gains are higher at: -2.082 vs. EKTAY (-18.245). EKTAY has higher annual earnings (EBITDA): 2.23B vs. SAUHY (721M). EKTAY has more cash in the bank: 2.76B vs. SAUHY (335M). EKTAY has higher revenues than SAUHY: EKTAY (17.8B) vs SAUHY (2.58B).
EKTAYSAUHYEKTAY / SAUHY
Capitalization1.71B19.1B9%
EBITDA2.23B721M310%
Gain YTD-18.245-2.082876%
P/E Ratio58.4436.14162%
Revenue17.8B2.58B690%
Total Cash2.76B335M824%
Total Debt7.74BN/A-
FUNDAMENTALS RATINGS
EKTAY vs SAUHY: Fundamental Ratings
EKTAY
SAUHY
OUTLOOK RATING
1..100
8763
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
8452
PRICE GROWTH RATING
1..100
8056
P/E GROWTH RATING
1..100
588
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKTAY's Valuation (6) in the null industry is in the same range as SAUHY (36). This means that EKTAY’s stock grew similarly to SAUHY’s over the last 12 months.

SAUHY's Profit vs Risk Rating (88) in the null industry is in the same range as EKTAY (100). This means that SAUHY’s stock grew similarly to EKTAY’s over the last 12 months.

SAUHY's SMR Rating (52) in the null industry is in the same range as EKTAY (84). This means that SAUHY’s stock grew similarly to EKTAY’s over the last 12 months.

SAUHY's Price Growth Rating (56) in the null industry is in the same range as EKTAY (80). This means that SAUHY’s stock grew similarly to EKTAY’s over the last 12 months.

EKTAY's P/E Growth Rating (5) in the null industry is significantly better than the same rating for SAUHY (88). This means that EKTAY’s stock grew significantly faster than SAUHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKTAYSAUHY
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 10 days ago
64%
Bullish Trend 11 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
EKTAY
Daily Signal:
Gain/Loss:
SAUHY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEVZX13.950.13
+0.94%
Columbia Global Value Inst
POGCX57.780.20
+0.35%
Putnam Large Cap Growth C
ALMRX26.81N/A
N/A
Alger Mid Cap Growth Institutional I
FSGRX22.81N/A
N/A
Franklin Small Cap Growth A
HSLCX40.68N/A
N/A
Hartford Small Cap Growth C

EKTAY and

Correlation & Price change

A.I.dvisor tells us that EKTAY and SAUHY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKTAY and SAUHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKTAY
1D Price
Change %
EKTAY100%
+1.38%
SAUHY - EKTAY
31%
Poorly correlated
+3.78%
SMMNY - EKTAY
29%
Poorly correlated
+2.51%
PHG - EKTAY
29%
Poorly correlated
+2.06%
GNGBY - EKTAY
26%
Poorly correlated
+2.30%
NEOG - EKTAY
26%
Poorly correlated
+5.64%
More

SAUHY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAUHY has been loosely correlated with SONVY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SAUHY jumps, then SONVY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAUHY
1D Price
Change %
SAUHY100%
+3.78%
SONVY - SAUHY
49%
Loosely correlated
+1.05%
ALGN - SAUHY
49%
Loosely correlated
+7.34%
SAUHF - SAUHY
47%
Loosely correlated
+3.08%
SMMNY - SAUHY
44%
Loosely correlated
+2.51%
CZMWY - SAUHY
38%
Loosely correlated
+3.18%
More